Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-25-030015
Filing Date
2025-02-28
Accepted
2025-02-28 16:15:38
Documents
16
Effectiveness Date
2025-02-28

Document Format Files

Seq Description Document Type Size
1 S-8 kura-20250227.htm S-8 116159
2 EX-5.1 kura-ex5_1.htm EX-5.1 16663
3 EX-23.1 kura-ex23_1.htm EX-23.1 3525
4 EX-FILING FEES kura_exfilingfees.htm   iXBRL EX-FILING FEES 34320
5 GRAPHIC img190708051_0.jpg GRAPHIC 90263
  Complete submission text file 0000950170-25-030015.txt   430969

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT kura_exfilingfees_htm.xml XML 8207
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

EIN.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285424 | Film No.: 25690412
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)